Business
Psychedelic biotech Psylo raises first funds – The Australian Financial Review
Startmate company Psylo is the latest company to attract funding for its pre-clinical psychedelic research.
The space is also attracting big investment dollars in the US, UK and Europe, with Beckley Psytech raising $US80 million in August, Atai Life Sciences raising $225 million for a NASDAQ listing in 2020 and new Chicago-based venture capital group Palo Santo…
Continue Reading
-
Noosa News16 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News17 hours agoMotorcyclist dies in crash with truck
-
Noosa News18 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
General23 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging